Gilead Sciences submits NDA in U.S. for bictegravir/emtricitabine/tenofovir alafenamide June 13, 2017 No Comments
Researchers develop a novel assay to quantify inducible, replication competent latent HIV-1 June 6, 2017 No Comments
U.S. and E.U. submissions made for dolutegravir/rilpivirine single-tablet regimen for HIV-1 June 2, 2017 No Comments
Four phase III studies of bictegravir/emtricitabine/tenofovir alafenamide meet primary endpoints May 31, 2017 No Comments
Preliminary results show nearly 100% immune response rates in clinical study of Pennvax-GP May 25, 2017 No Comments
Quadruplex sgRNAs/saCas9 AAV gene therapy results in successful HIV-1 provirus excision in vivo May 16, 2017 No Comments
TaiMed submits ibalizumab BLA to FDA for treatment of multidrug-resistant HIV-1 May 4, 2017 No Comments
RSS